Pharmaceutical Business review

AxoGen raises $12.1 million through venture finance

In July 2007, AxoGen established itself in the nerve regeneration field with the launch of Avance nerve graft for peripheral nerve repair.

Jamie Grooms, CEO and co-founder of AxoGen, said: “This round of funding will enable us to provide the Avance nerve graft to more surgeons, giving them a new solution to repair and regenerate peripheral nerves.”